Merck (MRK +0.3%) announces that
Ervebo (Ebola Zaire Vaccine, Live) is now approved in Democratic
Republic of Congo, Burundi, Ghana and Zambia for prevention of disease
caused by Zaire ebolavirus in people at least 18 years old.
https://seekingalpha.com/news/3542292-merck-ebola-vaccine-okd-in-four-african-countries
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.